Advanced Biomed Inc.

ADVB · NASDAQ

Advanced Biomed has historical cancer-diagnostics technology, but the latest filings show no product revenue, a reverse split, a short-term loan, a subsidiary divestiture, and an April 2026 pivot into AI.

Follow Add to Watchlist Ask Question

NASDAQ ADVB Coverage Bootstrap Diagnostics Artificial Intelligence Microcap

Latest ReportMay 14, 2026Advanced Biomed: The No-Revenue Biotech That Just Swerved Into AIView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->

Admin-only preview

Valuation is limited to admins for now.

The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.